Nek2C functions as a tumor promoter in human breast tumorigenesis

International Journal of Molecular Medicine

Volumn 30, Issue 4, 2012, Pages 775-782

  Liu, Ziyu ^a   Wang, Yahong ^a   Wang, Shuling ^a   Zhang, Jing ^a   Zhang, Fei ^a   Niu, Yun ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Breast cancer; MCF10 cell lines; Nek2C

Indexed keywords

MESSENGER RNA; NEK2 PROTEIN; PROTEIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; ATYPICAL DUCTAL HYPERPLASIA; BREAST CANCER; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRADUCTAL CARCINOMA; PRIORITY JOURNAL; RNA INTERFERENCE; UPREGULATION;

BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERPLASIA; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84866513094     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1069     Document Type: Article

References (27)

1. Fletcher L, Cerniglia GJ, Nigg EA, Yend TJ and Muschel RJ: Inhibition of centrosome separation after DNA damage: a role for Nek2. Radiat Res 162: 128-135, 2004. (Pubitemid 39100011)
2. Fry AM: The Nek2 protein kinase: a novel regulator of centrosome structure. Oncogene 21: 6184-6194, 2002.
3. O'Connell MJ, Krien MJ and Hunter T: Never say never. The NIMA-related protein kinases in mitotic control. Trends Cell Biol 13: 221-228, 2003. (Pubitemid 36556006)
4. Fry AM, Meraldi P and Nigg EA: A centrosomal function for the human Nek2 protein kinase, a member of the NIMA family of cell cycle regulators. EMBO J 17: 470-481, 1998. (Pubitemid 28045488)
5. Guo HQ, Gao M, Ma J, Xiao T, Zhao LL, Gao Y and Pan QJ: Analysis of the cellular centrosome in fine-needle aspirations of the breast. Breast Cancer Res 9: R48, 2007.
6. Lingle WL, Lutz WH, Ingle JN, Maihle NJ and Salisbury JL: Centrosome hypertrophy in human breast tumors: Implications for genomic stability and cell polarity. Proc Natl Acad Sci USA 95: 2950-2955, 1998. (Pubitemid 28135835)
7. Liu Q, Hirohashi Y, Du X, Greene MI and Wang Q: Nek2 targets the mitotic checkpoint proteins Mad2 and Cdc20: a mechanism for aneuploidy in cancer. Exp Mol Pathol 88: 225-233, 2010.
8. Hayward DG and Fry AM: Nek2 kinase in chromosome instability and cancer. Cancer Lett 237: 155-166, 2006. (Pubitemid 43777084)
9. Hayward DG, Clarke RB, Faragher AJ, Pillai MR, Hagan IM and Fry AM: The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer. Cancer Res 64: 7370-7376, 2004. (Pubitemid 39372076)
10. de Vos S, Hofmann WK, Grogan TM, et al: Gene expression profile of serial samples of transformed B-cell lymphomas. Lab Invest 83: 271-285, 2003. (Pubitemid 36255371)
11. Uto K, Nakajo N and Sagata N: Two structural variants of Nek2 kinase, termed Nek2A and Nek2B, are differentially expressed in Xenopus tissues and development. Dev Biol 208: 456-464, 1999. (Pubitemid 29184003)
12. Fardilha M, Wu W, Sa R, et al: Alternatively spliced protein variants as potential therapeutic targets for male infertility and contraception. Ann NY Acad Sci 1030: 468-478, 2004. (Pubitemid 40378948)
13. Worsham MJ, Pals G, Schouten JP, Miller F, Tiwari N, van Spaendonk R and Wolman SR: High-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 model. Breast Cancer Res Treat 96: 177-186, 2006.
14. Vazquez-Martin A, Colomer R, Brunet J, Lupu R and Menendez JA: Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells. Cell Prolif 41: 59-85, 2008. (Pubitemid 351147647)
15. Wu W, Baxter JE, Wattam SL, et al: Alternative splicing controls nuclear translocation of the cell cycle-regulated Nek2 kinase. J Biol Chem 282: 26431-26440, 2007. (Pubitemid 47443796)
16. Wang S, Li W, Liu N, et al: Nek2A contributes to tumorigenic growth and possibly functions as potential therapeutic target for human breast cancer. J Cell Biochem 113: 1904-1914, 2012.
17. Moody SE, Perez D, Pan TC, et al: The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 8: 197-209, 2005. (Pubitemid 41317591)
18. D'Cruz CM, Gunther EJ, Boxer RB, et al: c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med 7: 235-239, 2001. (Pubitemid 32148492)
19. Gunther EJ, Moody SE, Belka GK, et al: Impact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesis. Genes Dev 17: 488-501, 2003. (Pubitemid 36258763)
20. Karagiannis TC and El- Osta A: RNA interference and potential therapeutic applications of short interfering RNAs. Cancer Gene Ther 12: 787-795, 2005.
21. Lu PY, Xie F and Woodle MC: In vivo application of RNA interference: from functional genomics to therapeutics. Adv Gen 54: 117-142, 2005.
22. Ameyar-Zazoua M, Guasconi V and Ait-Si-Ali S: siRNA as a route to new cancer therapies. Expert Opin Biol Ther 5: 221-224, 2005. (Pubitemid 40388851)
23. Fletcher L, Cerniglia GJ, Yen TJ and Muschel RJ: Live cell imaging reveals distinct roles in cell cycle regulation for Nek2A and Nek2B. Biochem Biophys Acta 1744: 89-92, 2005.
24. Lou Y, Yao J, Zereshki A, et al: NEK2A interacts with MAD1 and possibly functions as a novel integrator of the spindle checkpoint signaling. J Biol Chem 279: 20049-20057, 2004. (Pubitemid 38623449)
25. Yao J, Fu C, Ding X, et al : Nek2A kinase regulates the localization of numatrin to centrosome in mitosis. FEBS Lett 575: 112-118, 2004. (Pubitemid 39237691)
26. Tsunoda N, Kokuryo T, Oda K, et al: Nek2 as a novel molecular target for the treatment of breast carcinoma. Cancer Sci 100: 111-116, 2009.
27. Westwood I, Cheary DM, Baxter JE, Richards MW, van Montfort RL, Fry AM and Bayliss R: Insights into the conformational variability and regulation of human Nek2 kinase. J Mol Biol 386: 476-485, 2009.